RAYMOND JAMES & ASSOCIATES - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,022
-11.7%
15,480
+1.3%
0.00%
Q2 2023$6,823
-48.2%
15,280
-4.9%
0.00%
Q1 2023$13,178
-44.8%
16,071
+5.0%
0.00%
Q4 2022$23,868
-27.7%
15,300
-20.1%
0.00%
Q3 2022$33,000
-32.7%
19,157
-32.9%
0.00%
Q2 2022$49,000
-52.0%
28,571
+0.4%
0.00%
Q1 2022$102,000
-34.2%
28,471
-8.6%
0.00%
Q4 2021$155,000
-32.3%
31,141
-2.4%
0.00%
Q3 2021$229,000
+9.0%
31,921
+41.2%
0.00%
Q2 2021$210,000
-4.5%
22,614
-4.7%
0.00%
Q1 2021$220,000
-18.2%
23,725
-21.8%
0.00%
Q4 2020$269,000
-23.1%
30,358
+0.8%
0.00%
Q3 2020$350,000
-47.3%
30,130
+22.3%
0.00%
-100.0%
Q2 2020$664,000
+302.4%
24,629
+11.2%
0.00%
Q1 2020$165,000
+126.0%
22,158
-0.0%
0.00%
Q4 2019$73,000
+97.3%
22,163
+22.5%
0.00%
Q3 2019$37,000
-19.6%
18,088
+16.1%
0.00%
Q2 2019$46,000
-20.7%
15,5740.0%0.00%
Q1 2019$58,000
-43.1%
15,574
-38.7%
0.00%
Q4 2018$102,000
+61.9%
25,395
+122.5%
0.00%
Q3 2018$63,000
-6.0%
11,413
+12.9%
0.00%
Q1 2017$67,000
-8.2%
10,113
-3.8%
0.00%
Q4 2016$73,000
-38.1%
10,513
-17.3%
0.00%
Q3 2016$118,000
+12.4%
12,713
+12.4%
0.00%
Q2 2016$105,000
+16.7%
11,313
+9.8%
0.00%
Q1 2016$90,00010,3000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders